Mark Chin Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Mark Chin is of Pyxis Oncology, Inc.. Currently has a direct ownership of 66,831 shares of PYXS, which is worth approximately $118,959. The most recent transaction as insider was on Mar 31, 2022, when has been sold 66,831 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.8K
0% 3M change
0% 12M change
Total Value Held $118,959

Mark Chin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
BUY
Grant, award, or other acquisition
-
66,831 Added 50.0%
66,831 Common Stock

Also insider at

ITRM
Iterum Therapeutics plc Healthcare
Director
HARP
Harpoon Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
Director
GMTX
Gemini Therapeutics, Inc. Healthcare
MC

Mark Chin

Dublin, L2

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS